Synthesis 2024; 56(04): 603-610
DOI: 10.1055/s-0042-1751437
special topic
Synthetic Development of Key Intermediates and Active Pharmaceutical Ingredients (APIs)

Synthesis of Ledipasvir through a Late-Stage Cyclopropanation and Fluorination Process

Chennam Ramu
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
T. Kumaraguru
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
M. Sridhar Reddy
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
Haridas B. Rode
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
› Author Affiliations

Financial assistance from Council of Scientific and Industrial Research is gratefully acknowledged [CSIR mission mode project (HCP-0011)].


Preview

Abstract

We have designed and developed an easily accessible advanced intermediate of ledipasvir that allowed late-stage cyclopropanation and difluorination, thereby providing a novel and more efficient process for the preparation of ledipasvir in the longest linear sequence of 8 steps with 20% overall yield.

Supporting Information



Publication History

Received: 21 October 2022

Accepted after revision: 27 February 2023

Article published online:
13 April 2023

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany